{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:38:55Z","timestamp":1790174335270,"version":"4.1.0"},"reference-count":41,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Health and Welfare","award":["HR16C0001"],"award-info":[{"award-number":["HR16C0001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Systemic lupus erythematosus (SLE) is a heterogeneous disorder with diverse clinical manifestations. This study classified patients by combining laboratory values at SLE diagnosis via hierarchical cluster analysis. Linear discriminant analysis was performed to construct a model for predicting clusters. Cluster analysis using data from 389 patients with SLE yielded three clusters with different laboratory characteristics. Cluster 1 had the youngest age at diagnosis and showed significantly lower lymphocyte and platelet counts and hemoglobin and complement levels and the highest erythrocyte sedimentation rate (ESR) and anti-double-stranded DNA (dsDNA) antibody level. Cluster 2 showed higher white blood cell (WBC), lymphocyte, and platelet counts and lower ESR and anti-dsDNA antibody level. Cluster 3 showed the highest anti-nuclear antibody titer and lower WBC and lymphocyte counts. Within approximately 171 months, Cluster 1 showed higher SLE Disease Activity Index scores and number of cumulative manifestations, including malar rash, alopecia, arthritis, and renal disease, than did Clusters 2 and 3. However, the damage index and mortality rate did not differ significantly between them. In conclusion, the cluster analysis using the initial laboratory findings of the patients with SLE identified three clusters. While disease activities, organ involvements, and management patterns differed between the clusters, damages and mortalities did not.<\/jats:p>","DOI":"10.3390\/jcm11092406","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T21:16:28Z","timestamp":1650921388000},"page":"2406","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Three Clinical Clusters Identified through Hierarchical Cluster Analysis Using Initial Laboratory Findings in Korean Patients with Systemic Lupus Erythematosus"],"prefix":"10.3390","volume":"11","author":[{"given":"Ju-Yang","family":"Jung","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Ajou University School of Medicine, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4169-8284","authenticated-orcid":false,"given":"Hyun-Young","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Ajou University School of Medicine, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9440-9119","authenticated-orcid":false,"given":"Eunyoung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Ajou University School of Medicine, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2609-3367","authenticated-orcid":false,"given":"Hyoun-Ah","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ajou University School of Medicine, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1635-8376","authenticated-orcid":false,"given":"Dukyong","family":"Yoon","sequence":"additional","affiliation":[{"name":"Center for Digital Health, Yongin Severance Hospital, Yonsei University Health System, Yongin 16995, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6156-393X","authenticated-orcid":false,"given":"Chang-Hee","family":"Suh","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ajou University School of Medicine, Suwon 16499, Korea"},{"name":"Department of Molecular Science and Technology, Ajou University, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","article-title":"Systemic lupus erythematosus","volume":"384","author":"Lisnevskaia","year":"2014","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.rdc.2015.08.008","article-title":"Corticosteroids in lupus nephritis and central nervous system lupus","volume":"42","author":"Kamen","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10067-016-3492-6","article-title":"Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus","volume":"36","author":"Tarr","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/rheumatology\/keab362","article-title":"All-cause and Cause-specific Mortality in Systemic Lupus Erythematosus: A Population-based Study","volume":"61","author":"Moghaddam","year":"2021","journal-title":"Rheumatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/annrheumdis-2018-214802","article-title":"All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971\u20132013)","volume":"78","author":"Tselios","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3899\/jrheum.150985","article-title":"Predictors of organ damage progression and effect on health-related quality of life in systemic lupus erythematosus","volume":"43","author":"Legge","year":"2016","journal-title":"J. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1529-0131(200104)45:2<191::AID-ANR173>3.0.CO;2-2","article-title":"Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group","volume":"45","author":"McGwin","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/0961203319860579","article-title":"Factors predictive of serious infections over time in systemic lupus erythematosus patients: Data from a multi-ethnic, multi-national, Latin American lupus cohort","volume":"28","author":"Harvey","year":"2019","journal-title":"Lupus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.rdc.2014.04.003","article-title":"Pathogenesis and treatment of atherosclerosis in lupus","volume":"40","author":"McMahon","year":"2014","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"102615","DOI":"10.1016\/j.jaut.2021.102615","article-title":"Clinical disease activity and flare in SLE: Current concepts and novel biomarkers","volume":"119","author":"Thanou","year":"2021","journal-title":"J. Autoimmun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.autrev.2015.02.008","article-title":"Assessment of disease activity in systemic lupus erythematosus: Lights and shadows","volume":"14","author":"Ceccarelli","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"ref_12","first-page":"S85","article-title":"Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care","volume":"32","author":"Tani","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_13","first-page":"S37","article-title":"Measures of adult systemic lupus erythematosus: Updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage Index (SDI)","volume":"63","author":"Isenberg","year":"2011","journal-title":"Arthritis Care Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Yu, J., Zeng, T., Wu, Y., Tian, Y., Tan, L., Duan, X., Wu, Q., Li, H., and Yu, L. (2019). Neutrophil-to-C3 ratio and neutrophil-to-lymphocyte ratio were associated with disease activity in patients with systemic lupus erythematosus. J. Clin. Lab. Anal., 33.","DOI":"10.1002\/jcla.22633"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.20980","article-title":"Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus","volume":"52","author":"Linnik","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_16","first-page":"373","article-title":"The Systemic Lupus International Collaborating Clinics\/American College of Rheumatology (SLICC\/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison","volume":"27","author":"Gladman","year":"2000","journal-title":"J. Rheumatol."},{"key":"ref_17","unstructured":"Touma, Z., Hoskin, B., Atkinson, C., Bell, D., Massey, O., Lofland, J.H., Berry, P., Karyekar, C.S., and Costenbader, K.H. Systemic lupus erythematosus symptom clusters and their association with patient-reported outcomes and treatment: Analysis of real-world data. Arthritis Care Res., 2020."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s10067-020-05480-y","article-title":"Lymphocyte subset clustering analysis in treatment-naive patients with systemic lupus erythematosus","volume":"40","author":"Lu","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/1756-185X.13745","article-title":"Identifying damage clusters in patients with systemic lupus erythematosus","volume":"23","author":"Ahn","year":"2020","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/jalm\/jfab140","article-title":"The International Consensus on ANA Patterns (ICAP) in 2021-The 6th Workshop and Current Perspectives","volume":"7","author":"Chan","year":"2022","journal-title":"J. Appl. Lab. Med."},{"key":"ref_23","first-page":"1934","article-title":"The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus","volume":"31","author":"Uribe","year":"2004","journal-title":"J. Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1525-1578(10)60455-2","article-title":"Analysis of microarray data using Z score transformation","volume":"5","author":"Cheadle","year":"2003","journal-title":"J. Mol. Diagn."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00357-014-9161-z","article-title":"Ward\u2019s hierarchical agglomerative clustering method: Which algorithms implement ward\u2019s criterion?","volume":"31","author":"Murtagh","year":"2014","journal-title":"J. Classific."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.autrev.2013.11.007","article-title":"Patterns of systemic lupus erythematosus expression in Europe","volume":"13","author":"Cervera","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1177\/0961203309345767","article-title":"Prognostically distinct clinical patterns of systemic lupus erythematosus identified by cluster analysis","volume":"18","author":"To","year":"2009","journal-title":"Lupus"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/rheumatology\/kew049","article-title":"Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry","volume":"55","author":"Lois","year":"2016","journal-title":"Rheumatology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3899\/jrheum.140677","article-title":"Four anti-dsDNA antibody assays in relation to systemic lupus erythematosus disease specificity and activity","volume":"42","author":"Enocsson","year":"2015","journal-title":"J. Rheumatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1177\/0961203316640922","article-title":"Autoantibodies, complement and type I interferon as biomarkers for personalized medicine in SLE","volume":"25","author":"Biesen","year":"2016","journal-title":"Lupus"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2016.08.001","article-title":"Lupus nephritis biomarkers","volume":"185","author":"Soliman","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.autrev.2005.06.004","article-title":"Systemic lupus erythematosus in Europe at the change of the millennium: Lessons from the \u201cEuro-Lupus Project\u201d","volume":"5","author":"Cervera","year":"2006","journal-title":"Autoimmun. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/rheumatology\/keq269","article-title":"The management of peripheral blood cytopenias in systemic lupus erythematosus","volume":"49","author":"Hepburn","year":"2010","journal-title":"Rheumatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/0961203306071916","article-title":"Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia","volume":"15","author":"Cabiedes","year":"2006","journal-title":"Lupus"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/0961203320969806","article-title":"Impact of autoimmune cytopenias on severity of childhood-onset systemic lupus erythematosus: A single-center retrospective cohort study","volume":"30","author":"Ogbu","year":"2021","journal-title":"Lupus"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-3083.2006.01819.x","article-title":"Autoantibody determination in the diagnosis of systemic lupus erythematosus","volume":"64","author":"Kurien","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-3083.2012.02728.x","article-title":"Antinuclear antibodies in rheumatic disease: A proposal for a function-based classification","volume":"76","author":"Pisetsky","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/art.10561","article-title":"Evidence-based guidelines for the use of immunologic tests: Antinuclear antibody testing","volume":"47","author":"Solomon","year":"2002","journal-title":"Arthritis Rheum."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar3258","article-title":"Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden","volume":"13","author":"Eriksson","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/annrheumdis-2021-221295","article-title":"Flares after hydroxychloroquine reduction or discontinuation: Results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort","volume":"81","author":"Hanly","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3899\/jrheum.170645","article-title":"More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus","volume":"45","author":"Pakchotanon","year":"2018","journal-title":"J. Rheumatol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/9\/2406\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:00:45Z","timestamp":1760137245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/9\/2406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["jcm11092406"],"URL":"https:\/\/doi.org\/10.3390\/jcm11092406","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]}}}